Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 10 of 23

Publication Record

Connections

Impact of body composition on outcomes from anti-PD1 +/- anti-CTLA-4 treatment in melanoma.
Young AC, Quach HT, Song H, Davis EJ, Moslehi JJ, Ye F, Williams GR, Johnson DB
(2020) J Immunother Cancer 8:
MeSH Terms: Body Composition, CTLA-4 Antigen, Female, Humans, Immunotherapy, Male, Melanoma, Middle Aged, Progression-Free Survival, Treatment Outcome
Added September 29, 2020
0 Communities
1 Members
0 Resources
10 MeSH Terms
Demographic Factors Associated with Toxicity in Patients Treated with Anti-Programmed Cell Death-1 Therapy.
Shah KP, Song H, Ye F, Moslehi JJ, Balko JM, Salem JE, Johnson DB
(2020) Cancer Immunol Res 8: 851-855
MeSH Terms: Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Antineoplastic Agents, Immunological, CTLA-4 Antigen, Female, Hospitalization, Humans, Immunologic Factors, Immunotherapy, Length of Stay, Male, Melanoma, Middle Aged, Programmed Cell Death 1 Receptor, Risk Factors, Young Adult
Added May 29, 2020
0 Communities
1 Members
0 Resources
19 MeSH Terms
Increased reporting of fatal hepatitis associated with immune checkpoint inhibitors.
Vozy A, De Martin E, Johnson DB, Lebrun-Vignes B, Moslehi JJ, Salem JE
(2019) Eur J Cancer 123: 112-115
MeSH Terms: Adolescent, Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, B7-H1 Antigen, CTLA-4 Antigen, Chemical and Drug Induced Liver Injury, Child, Databases, Factual, Female, Hepatitis, Autoimmune, Humans, Ipilimumab, Male, Massive Hepatic Necrosis, Middle Aged, Neoplasms, Nivolumab, Programmed Cell Death 1 Receptor, World Health Organization, Young Adult
Added November 12, 2019
0 Communities
1 Members
0 Resources
23 MeSH Terms
Immune checkpoint inhibitor-associated hypophysitis-World Health Organisation VigiBase report analysis.
Guerrero E, Johnson DB, Bachelot A, Lebrun-Vignes B, Moslehi JJ, Salem JE
(2019) Eur J Cancer 113: 10-13
MeSH Terms: Adult, Aged, Aged, 80 and over, Antibodies, Monoclonal, Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, B7-H1 Antigen, CTLA-4 Antigen, Databases, Factual, Female, Humans, Hypophysitis, Ipilimumab, Male, Middle Aged, Nivolumab, Pharmacovigilance, Programmed Cell Death 1 Receptor, World Health Organization, Young Adult
Added November 12, 2019
0 Communities
1 Members
0 Resources
20 MeSH Terms
Biomarkers for assessing the effectiveness of immunotherapy in breast cancer.
Nixon MJ, Balko JM
(2018) Biomark Med 12: 97-100
MeSH Terms: B7-H1 Antigen, Biomarkers, Tumor, Breast Neoplasms, CTLA-4 Antigen, Female, Humans, Immunotherapy, Ipilimumab, Triple Negative Breast Neoplasms
Added March 14, 2018
0 Communities
1 Members
0 Resources
9 MeSH Terms
Cytotoxic T-lymphocyte antigen-4 single nucleotide polymorphisms are not associated with outcomes after unrelated donor transplantation: a center for international blood and marrow transplant research analysis.
Sengsayadeth S, Wang T, Lee SJ, Haagenson MD, Spellman S, Fernandez Viña MA, Muller CR, Verneris MR, Savani BN, Jagasia M
(2014) Biol Blood Marrow Transplant 20: 900-3
MeSH Terms: Adolescent, Adult, Aged, CTLA-4 Antigen, Female, Hematopoietic Stem Cell Transplantation, Humans, Leukemia, Myeloid, Acute, Male, Middle Aged, Multivariate Analysis, Myelodysplastic Syndromes, Polymorphism, Single Nucleotide, Treatment Outcome, Unrelated Donors, Young Adult
Added March 20, 2014
0 Communities
1 Members
0 Resources
16 MeSH Terms
In vitro induction of regulatory CD4+CD8α+ T cells by TGF-β, IL-7 and IFN-γ.
Van Kaer L, Rabacal WA, Scott Algood HM, Parekh VV, Olivares-Villagómez D
(2013) PLoS One 8: e67821
MeSH Terms: Adoptive Transfer, Animals, Antigens, CD, Antigens, Differentiation, CD4 Antigens, CD8 Antigens, CTLA-4 Antigen, Cell Differentiation, Cell Lineage, Core Binding Factor Alpha 3 Subunit, Cytokines, Immunophenotyping, Interferon-gamma, Interleukin-7, Intestinal Mucosa, Mice, Mice, Knockout, NK Cell Lectin-Like Receptor Subfamily K, Programmed Cell Death 1 Receptor, T-Lymphocytes, Regulatory, Transforming Growth Factor beta, Vitamin D
Added March 7, 2014
0 Communities
3 Members
0 Resources
22 MeSH Terms
Genetic variation in donor CTLA-4 regulatory region is a strong predictor of outcome after allogeneic hematopoietic cell transplantation for hematologic malignancies.
Jagasia M, Clark WB, Brown-Gentry KD, Crawford DC, Fan KH, Chen H, Kassim A, Greer JP, Engelhardt BG, Savani BN
(2012) Biol Blood Marrow Transplant 18: 1069-75
MeSH Terms: Adolescent, Adult, Aged, CTLA-4 Antigen, Female, Graft vs Tumor Effect, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, Humans, Male, Middle Aged, Polymorphism, Single Nucleotide, Risk Factors, Secondary Prevention, Survival Analysis, T-Lymphocytes, Cytotoxic, Tissue Donors, Transplantation, Homologous, Treatment Outcome
Added December 10, 2013
0 Communities
3 Members
0 Resources
19 MeSH Terms
Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis.
Mkhikian H, Grigorian A, Li CF, Chen HL, Newton B, Zhou RW, Beeton C, Torossian S, Tatarian GG, Lee SU, Lau K, Walker E, Siminovitch KA, Chandy KG, Yu Z, Dennis JW, Demetriou M
(2011) Nat Commun 2: 334
MeSH Terms: Animals, Antigens, CD, CTLA-4 Antigen, Case-Control Studies, Cholecalciferol, Cohort Studies, Down-Regulation, Female, Genetic Variation, Glycosylation, Haplotypes, Humans, Male, Mice, Mice, Inbred Strains, Multiple Sclerosis, N-Acetylglucosaminyltransferases, Receptors, Interleukin-2, Receptors, Interleukin-7, Risk Factors, Signal Transduction, Sunlight
Added November 15, 2013
0 Communities
1 Members
0 Resources
22 MeSH Terms
Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence.
Zhang B, Beeghly-Fadiel A, Long J, Zheng W
(2011) Lancet Oncol 12: 477-88
MeSH Terms: Antigens, CD, Aromatase, Ataxia Telangiectasia Mutated Proteins, Breast Neoplasms, CTLA-4 Antigen, Caspase 8, Cell Cycle Proteins, Checkpoint Kinase 2, DNA-Binding Proteins, Evidence-Based Medicine, Female, Genetic Predisposition to Disease, Humans, Mutation, Nuclear Proteins, Protein Serine-Threonine Kinases, Risk Assessment, Risk Factors, Telomerase, Tumor Suppressor Protein p53, Tumor Suppressor Proteins
Added December 10, 2013
0 Communities
3 Members
0 Resources
21 MeSH Terms